CytoDyn raises ~$6.5M in unregistered equity offerings

CytoDyn Inc.

Received subscription agreements for ~24.4M units (1 share + 3/4 warrant) from accredited investors via placement agent.
Gross proceeds of ~$6.2M from placement agent offering; price per unit set at 85% of volume-weighted avg price.
Issued 625,000 shares and 312,500 warrants to accredited investor on April 5, 2022, for $0.25M.
Warrants have 5-year term; company will file registration statement within 90 days of final closing.
Additional ~4.6M shares and ~5.5M warrants may be issuable under adjustment provisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.